Transient receptor potential channels in Flaviviridae infection: A comprehensive review Authors: Fuchun Jiang, Xiaoqiang Yao, Chang-Bo Zheng Published: 2026 ABSTRACT ABSTRACTDiseases caused by Flaviviridae viruses exert profound global health and economic burdens due to their high incidence and associated mortality. Infection by the Flaviviridae family often leads to severe acute or chronic illnesses, including hemorrhagic systemic diseases caused by dengue virus (DENV) and yellow fever virus, neurological complications associated with West Nile virus and Zika virus (ZIKV) infection, as well as liver damage and hepatocellular carcinoma resulting from hepatitis C virus (HCV) infection. Accumulating evidence indicates that a hallmark of Flaviviridae infection is to hijack calcium (Ca2+) signaling of the host cells, consequently facilitating viral entry, RNA replication, viral assembly, and release. Transient receptor potential (TRP) channels, a superfamily of nonselective cation channels, are central regulators of intracellular Ca2+ homeostasis. Recent studies reveal that TRP channels are closely involved in Flaviviridae infection. This comprehensive review synthesizes current findings on the role of TRP channels (e.g. TRPC, TRPV, TRPA, TRPM, and TRPML) in the pathogenesis of Flaviviridae viruses such as DENV, ZIKV, HCV, and Japanese encephalitis virus. Moreover, this review summarizes virus-TRP channel interaction mechanisms and discusses the potential of targeting TRP channels for host-directed antiviral therapies. This review aims to establish a conceptual framework for understanding TRP channel biology in Flaviviridae infection and to guide future research on antiviral strategies. Future directions should highlight the potential utility of TRP channel research for advancing anti-Flaviviridae therapies and clarifying their underlying mechanisms. Introduction The Flaviviridae family comprises a diverse group of enveloped, single-stranded positive-sense RNA viruses that present substantial threats to global public health and animal industries [1]. The infection caused by these viruses has reached endemic levels across more than 100 countries and regions, affecting hundreds of millions of individuals and often leading to severe complications [2]. Members of the Flavivirus genus, such as dengue virus (DENV), Zika virus (ZIKV), yellow fever virus (YFV), and Japanese encephalitis virus (JEV), are primarily transmitted through blood-sucking arthropods (e.g. mosquitoes and ticks) [3], resulting in over 400 million human infections each year [4]. Clinical outcomes range from mild febrile illness to hemorrhagic fever (as seen with DENV and YFV) and even encephalitis associated with ZIKV and JEV infections [5]. Meanwhile, the Hepacivirus genus includes human hepatitis C virus (HCV), a blood-borne pathogen that chronically infects approximately 58 million people worldwide and can progress to chronic liver disease, cirrhosis, and hepatocellular carcinoma [6]. Pestiviruses, such as classical swine fever virus and bovine viral diarrhea virus, also cause considerable economic losses in livestock production, further highlighting the wide-ranging impact of this viral family [7]. Although effective vaccines exist for some Flaviviruses like JEV [8] and YFV [9], outbreaks continue to emerge due to factors such as globalization and urbanization [10], which facilitate disease vector reestablishment and human transmission. Moreover, the absence of broadly effective vaccines or FDA-approved antiviral treatments leaves nearly 3.9 billion people, largely in low-income regions, vulnerable to infection [11,12]. Therefore, a comprehensive understanding of the biological characteristics of Flaviviruses is urgently needed. A defining characteristic of Flaviviridae infection is the strategic manipulation of host cellular signaling to support viral entry, replication, assembly, and release. Notably, these viruses often induce host cell dysfunction and disrupt intracellular calcium (Ca2+) homeostasis [13]. As a ubiquitous second messenger, Ca2+ is critical for virtually all physiological processes in the humans [14]. Over recent decades, transient receptor potential (TRP) channels, a family of polymodal cation channels with high selectivity for Ca2+, have attracted growing research interest due to their central role in maintaining intra- and extracellular Ca2+ homeostasis [15]. Previous studies have proved that dysregulation of TRP-mediated Ca2+ signaling, along with ensuing physiopathological alterations, acts as a key driver in the progression of viral infectious diseases. TRP channels are categorized into seven subfamilies (TRPC, TRPV, TRPM, TRPN, TRPA, TRPP, TRPML) based on structural homology, and they respond to diverse stimuli (e.g. osmotic pressure, pH, mechanical force, ligands) to maintain Ca2+ flux [16]. Beyond their physiological functions in sensory transduction and cellular metabolism, TRP channels are increasingly recognized as critical mediators of viral infection, functioning as “molecular gatekeepers” that pathogens co-opt or disrupt to promote their replication and spread [17]. Previous studies have confirmed that TRP subfamilies (e.g. TRPC and TRPML) promote the replication of herpes simplex virus type 1 into cells by regulating store-operated Ca2+ entry or endosomal Ca2+ release [18,19]. Similarly, TRPV4 overexpression is found to enhance the entry and replication of Flaviviruses such as HCV, ZIKV, and DENV via increased Ca2+ influx [20]. Conversely, pharmacological inhibition of TRP channels, including TRPML [21], TRPC4 [22], and TRPV1 [23], has been shown to reduce Flavivirus infection and dissemination. Despite these insights, a systematic analysis of the role and mechanisms of TRP channels across Flaviviridae infection remains lacking. This review addresses these gaps by synthesizing existing evidence on TRP channels in Flaviviridae infection. We summarize the structural and functional diversity of TRP channels and discuss their contributions to the life cycles of major Flaviviridae pathogens. Moreover, we further explore mechanistic aspects, such as interactions between viral infection and TRP channels, and the modulation of Ca2 -dependent signaling cascades. Furthermore, we evaluate the therapeutic potential of targeting TRP channels for antiviral strategies. By synthesizing these findings, this review provides a cohesive framework for understanding how TRP channels affect Flaviviridae infection and offers directions for developing novel antiviral strategies. Overview of Flaviviridae structure and infection The Flaviviridae family, a group of enveloped single-stranded positive-sense RNA genome that encodes three structural proteins (including capsid (C), premembrane/membrane, and envelope (E)) and seven nonstructural proteins (e.g. NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) [24], encompasses various pathogens that pose significant threats to human and animal health. This family consists of four genera: Flavivirus, Hepacivirus, Pegivirus, and Pestivirus [25]. Viruses in the Flavivirus genus are primarily transmitted by blood-feeding arthropods (such as mosquitoes, ticks, and sandflies) and can infect humans, causing a range of clinical symptoms, including fever, headache, back pain, conjunctival congestion, rash, and severe hemorrhagic fever [26,27]. The Flavivirus genus contains over 70 members [28], including well-known human pathogens like ZIKV, DENV, JEV, WNV, and YFV. Another important genus within Flaviviridae is Hepacivirus, which includes the blood-borne human HCV that contributes to the occurrence and progression of liver fibrosis, cirrhosis, and hepatocellular carcinoma [29,30]. Moreover, the Pestivirus genus are zoonotic pathogens that impact on human health [31], which includes bovine viral diarrhea virus (BVDV), classical swine fever virus (CSFV), and border disease virus (BDV). Numerous studies have confirmed that Flaviviridae viruses have been detected in infected animals and humans and cause major public health concerns worldwide [32]. Functionally, viruses are adept at disrupting the Ca2+ homeostasis of host cells, which helps the viruses to achieve successful infections. Meanwhile, Ca2+ homeostasis disruption is a hallmark of viral infection [33]. As a ubiquitous second messenger, Ca2+ signaling participates in the regulation of a wide variety of physiological and biochemical processes, including the invasion, replication, proliferation, and release of Flaviviridae viruses [34,35]. Other studies have found that Flaviviridae infection facilitates Ca2+ signaling activation [36,37] and that Ca2+ signaling can serve as a potential therapeutic target for viral infection [38]. Herein, the functional role of Ca2+ signaling in Flaviviridae infection is summarized in Figure 1. Figure 1.Ca2+ signaling involved in the life cycle of Flaviviridae viruses.It begins with viral entry through VGCC, ORAI1 and TRP channels, leading to an influx of calcium ions. The virus releases its RNA, initiating viral replication in the endoplasmic reticulum. The process continues with viral assembly near the nucleus, facilitated by SPCA. Viral maturation occurs in the Golgi complex, assisted by STIM1. Finally, the mature virus is released from the cell. Key stages are labeled: 1) Viral entry, 2) Viral replication, 3) Viral assembly, 4) Viral maturation and 5) Viral release. The diagram highlights the role of calcium ion influx in the viral life cycle.Diagram of Flaviviridae life cycle: viral entry, replication, assembly, maturation and release in cytoplasm.Flaviviridae viruses drive the intracellular calcium overload and endosome membrane to release the nucleocapsid (RNA genetic material). Flaviviridae virus replication and virion assembly occur at the endoplasmic reticulum. Immature virion is then transported to the Golgi apparatus and the maturation happens in the trans-Golgi network. Viral particle is finally released outside the cell through exocytosis pathway. VGCC: voltage-gated Ca2+ channels; ORAI1: orai calcium release-activated calcium modulator 1; TRP: transient receptor potential; SPCA: secretory pathway Ca2+-ATPase; STIM1: stromal interaction molecule. Ca2+ signaling involved in the life cycle of Flaviviridae viruses. TRP channels TRP channels were first discovered in Drosophila in 1969. As key regulators of intracellular Ca2+ homeostasis, TRP channels play an important role in regulating host homeostasis and various viral infections [17]. Based on the homology of amino acid sequences, mammalian TRP channels were divided into seven main subfamilies (Figure 2A): TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPN (non-mechanoreceptor potential C), TRPA (ankyrin), TRPP (polycystin), and TRPML (mucolipin) [39]. Structurally, TRP channels have a conserved primary structure that consists of six transmembrane domains (S1-S6), two cytoplasmic domains (NH2 and COOH termini), and a pore-forming loop located between S5 and S6 (Figure 2B). Figure 2.Schematic diagram of the TRP channel family and structure.It includes TRPC (canonical) with TRPC1 to TRPC7, TRPV (vanilloid) with TRPV1 to TRPV6, TRPM (melastatin) with TRPM1 to TRPM8, TRPA/N (ankyrin) with TRPA1 and TRPN1, TRPP (polycystin) with TRPP2, TRPP3 and TRPP5 and TRPML (mucolipin) with TRPML1 to TRPML3. The image B shows the structure of TRP channels with six transmembrane domains labeled S1 to S6, two cytoplasmic domains labeled N and C and a pore-forming loop between S5 and S6. The diagram indicates the flow of calcium ions from extracellular to intracellular regions through the channel structure.Diagram of TRP channel subfamilies and structure with transmembrane domains.A: members of the TRP channel family; B: TRP channel structure. Schematic diagram of the TRP channel family and structure. Currently, TRP channels are widely distributed in human organs, including the trigeminal nerve, lung, liver, heart, kidney, intestinal tract, and spinal nerve. Previous studies have demonstrated that the activity of TRP channels can be regulated by multiple physical and chemical factors, such as osmotic pressure, cyclic nucleotides, mechanical force, and biochemical interactions involving ligands or cellular proteins [16,40]. Numerous studies have confirmed that TRP channels have been regarded as promising new therapeutic targets for various diseases, including cardiovascular diseases [41,42], cancer [43], pain [44], liver disease [45], inflammatory bowel disease [46], lung disease [47], rheumatoid arthritis [48], etc. In recent years, dysregulation of TRP channel-mediated Ca2+ homeostasis has been identified as a critical factor for the occurrence and prognosis of viral disease [17]. Role of TRP channels in Flaviviridae infection TRP channels in host cells can be used by viruses to promote their life cycle, including entry, replication, assembly, and export [49]. Understanding the interaction between the Flaviviridae family and TRP channels may provide novel therapeutic targets and antiviral drugs for diseases caused by Flaviviridae infection. Currently, five different subfamilies of TRP channels, including TRPC, TRPV, TRPA, TRPM, and TRPML, have been reported to interact with Flaviviridae infection. Herein, the functional role and mechanism of TRP channels in Flaviviridae infection are summarized in Table 1 and Figure 3. Figure 3.Regulatory role of TRP channel-mediated Ca2+ signaling in Flaviviridae infection.At the top, Flaviviridae viruses interact with TRP channels, including TRPAs, TRPCs, TRPVs, TRPMs and TRPMLs, leading to increased calcium ion influx. This influx causes endoplasmic reticulum stress and mitochondrial calcium ion overload, resulting in reactive oxygen species production. TRAF6 activates TBK, leading to phosphorylation of IRF3/7 and promoting type I interferon and inflammatory cytokine production. In the nucleus, AP-1 and NF-kappa B are involved in gene expression. Excessive inflammation and apoptosis occur via the NLRP3 inflammasome, leading to caspase activation and DNA fragmentation. The process culminates in viral infection, marked by excessive inflammation and apoptosis. The diagram highlights the complex interactions between viral components and host cellular mechanisms, emphasizing the role of TRP channels in the viral life cycle and immune response modulation.Flaviviridae infects via TRP channels, causing Ca2+ influx, ER stress and inflammation.TRP channels are involved in the host immune and inflammatory response. During this process, TRP channels activation and Ca2+ influx are involved. Flaviviridae virus infection caused TLR4 receptor activation and promoted MyD88 and NF-κB inflammatory pathway. Moreover, TRPAs, TRPCs, TRPVs, TRPMs, and TRPMLs are involved in the activation of the NLRP3 inflammasome, as well as the caspase activation. TLR: toll-like receptor; IRAK: IL-1 receptor-associated kinase; NF-κB: nuclear factor kappa-B; AP-1: activator protein-1; IRF: interferon regulatory factor; TBK: TANK-binding kinase; TRAF6: TNF receptor-associated factor 6; RIG-I: retinoic acid-inducible gene I; ERS: endoplasmic reticulum stress.Table 1.The expression and mechanisms of TRP channels in Flaviviridae infection.TRP channelExperimental modelExpressionEffect and mechanismsSpecific inhibitor/agonistRef.TRPC4ZIKV infectionCell: BHK cellsAnimal: A129 miceUpregulationPromoting the survival rate of ZIKV-infected cells and viral protein productionInhibitor: HC-070 and KN-93[22]TRPV1ZIKV infectionUpregulationPromoting inflammation/[23]TRPV4DENV, HCV, and ZIKV infectionCell: Huh7 cellsUpregulationPromoting viral replication/[20]TRPV4ZIKV infectionCell: Huh7 cellsUpregulationPromoting ZIKV infectivityInhibitor: NSC151066[50]TRPA1Yellow fever mosquito Aedes aegyptiCell: OocytesAnimal: MosquitoDownregulationInhibiting the life cycle of YFVAgonist: a bark extract of Cinnamosma fragrans[51]TRPM5HCV infectionUpregulationPromoting hepatic fibrosis progression in non-cirrhotic HCV-infected patients/[52]TRPMLsDENV2 and ZIKV infectionCell: A549 cellsDownregulationInhibiting viral entry and replicationAgonist: ML-SA1 and SN-2[21,53]TRPMLsJEV infectionCell: A549 cellsUpregulationPromoting JEV entry, egress, and infectionInhibitor: berbamine[54]TRPMLFlavivirus (DENV, JEV, ZIKV)Cell: A549 cellsUpregulationPromoting flavivirus entry and replicationInhibitor: bis-benzylisoquinoline alkaloids[55]TRPML2ZIKV infectionCell: A549 cellsDownregulationInhibiting ZIKV infectionAgonist: ML2-AS1[56] Regulatory role of TRP channel-mediated Ca2+ signaling in Flaviviridae infection. Table 1.The expression and mechanisms of TRP channels in Flaviviridae infection.TRP channelExperimental modelExpressionEffect and mechanismsSpecific inhibitor/agonistRef.TRPC4ZIKV infectionCell: BHK cellsAnimal: A129 miceUpregulationPromoting the survival rate of ZIKV-infected cells and viral protein productionInhibitor: HC-070 and KN-93[22]TRPV1ZIKV infectionUpregulationPromoting inflammation/[23]TRPV4DENV, HCV, and ZIKV infectionCell: Huh7 cellsUpregulationPromoting viral replication/[20]TRPV4ZIKV infectionCell: Huh7 cellsUpregulationPromoting ZIKV infectivityInhibitor: NSC151066[50]TRPA1Yellow fever mosquito Aedes aegyptiCell: OocytesAnimal: MosquitoDownregulationInhibiting the life cycle of YFVAgonist: a bark extract of Cinnamosma fragrans[51]TRPM5HCV infectionUpregulationPromoting hepatic fibrosis progression in non-cirrhotic HCV-infected patients/[52]TRPMLsDENV2 and ZIKV infectionCell: A549 cellsDownregulationInhibiting viral entry and replicationAgonist: ML-SA1 and SN-2[21,53]TRPMLsJEV infectionCell: A549 cellsUpregulationPromoting JEV entry, egress, and infectionInhibitor: berbamine[54]TRPMLFlavivirus (DENV, JEV, ZIKV)Cell: A549 cellsUpregulationPromoting flavivirus entry and replicationInhibitor: bis-benzylisoquinoline alkaloids[55]TRPML2ZIKV infectionCell: A549 cellsDownregulationInhibiting ZIKV infectionAgonist: ML2-AS1[56] The expression and mechanisms of TRP channels in Flaviviridae infection. TRPC As the earliest discovered members of the TRP family, TRPC channels are nonselective cation channels with molecular weights ranging from several tens to hundreds of kilodaltons [57]. Based on amino acid similarity, mammalian TRPC channels are classified into four subgroups: TRPC1, TRPC2, TRPC3/6/7, and TRPC4/5 [58]. Viruses can hijack TRPC channels in host cells to generate a favorable environment for viral entry. For example, knockdown of TRPC1 reduces herpes simplex virus type 1 (HSV-1) infection by enhancing Ca2+ influx and ameliorated HSV-1-induced ocular abnormality and morbidity in mice [19]. Of note, TRPC1 has been reported to be a component of the store-operated channels [59,60], which facilitates viral infection and pathogenesis by accelerating Ca2+ influx [61,62]. A recent study showed that suppression of TRPC4 inhibits the proliferation and spread of ZIKV and prevented ZIKV-associated seizures and death [22]. Collectively, TRPC channels are known to be involved in ZIKV infection, but their functional role and underlying mechanism in Flaviviridae infection is not fully understood. TRPV The TRPV channels belong to the vanilloid subtype of the TRP family, which comprises six members, namely TRPV1, TRPV2, TRPV3, TRPV4, TRPV5, and TRPV6. TRPV channels play a crucial regulatory role in the development of neuropathic pain [44,63], contributing to their function as sensors for diverse pain stimuli (e.g. heat, pressure, and pH). A recent study reported that TRPV1 ablation or antagonism ameliorates Chikungunya virus (CHIKV)-induced pain [64]. In addition, TRPV1 expression is enhanced in airway cells after respiratory virus infection [65]. Existing studies have reported that TRPV channels can regulate viral infection and represent a potential target for antiviral therapy. For example, TRPV1 deficiency reduces influenza A virus [66] replication. Deletion of TRPV2 restricts the replication and spread of Vesicular stomatitis virus [67] and HSV-2 [68] by promoting Ca2+ influx, as well as reduces inflammation induced by SARS-CoV-2 infection [69]. Zhang et al. [70] showed that overexpression of TRPV4 promotes HBV entry, replication, and capsid assembly. Another study showed that TRPV4 can serve as an effective biomarker for designing antiviral agents [50]. In the Flaviviridae family, inhibition of TRPV4 suppresses infectivity of DENV, HCV, and ZIKV by modulating Ca2+ influx [20]. Bhandari et al. [23] summarized that TRPV1 may serve as a novel therapeutic target for ZIKV-induced neurological complications. Mechanistically, targeting TRPV channels with agonists or antagonists can relieve various viral infection-induced inflammation. Vanwalscappel et al. [71] showed that toll-like receptor agonist R848 treatment restricts ZIKV replication in macrophages by enhancing antiviral protein viperin levels. Taken together, TRPV channels play an important role in the entry and replication of Flaviviridae. TRPA TRPA1, the only member of the TRPA channels in mammals, is known for its activation by various chemical irritants and viral infection [72]. Numerous studies have confirmed that TRPA1 expression is increased in host cells after viral infection, such as human rhinovirus [73] and respiratory viruses [65]. Meanwhile, reactive oxygen species (ROS) and inflammation, which often increase during viral infection, can activate TRPA1 [74,75]. Another study reported that mosquito saliva contains metabolites (e.g. sphingomyelins) that promotes Flavivirus transmission and enhances TRPA1 expression by suppressing host endoplasmic reticulum-associated degradation [76,77]. Meanwhile, inhibition of TRPA1 by Aedes aegypti salivary gland extract contributes to ameliorating acute itching [78]. Previous studies have proved that Flaviviridae infection increases mitochondrial ROS and inflammation [79,80], which can activate TRPA1, leading to Ca2+ overload and an enhanced viral genome translation. Notably, knockdown of TRPA1 reduces inflammation during Chikungunya virus infection in macrophages [81]. Bhandari et al. [23] proved that upregulation of TRPA1 promotes neurological complications caused by ZIKV infection. Collectively, TRPA1 may involve in Flaviviridae pathogenesis, but its specific mechanism still needs to be further explored. TRPM The TRPM channels belong to the melastatin group of TRP family, which comprises of eight members, including TRPM1-8. Out of these, TRPM2 and TRPM7 are often linked to responses to oxidative stress and inflammation [82], both of which are hallmarks of Flaviviridae infection. A recent study confirmed that TRPM2 deficiency attenuates H9N2 virus-induced lung injury by reducing oxidative stress, mitochondrial dysfunction, and inflammation [83]. Conversely, overexpression of TRMP2 enhances hepatitis B virus replication through autophagy induction [84]. In HIV infection, TRPM4 overexpression is found to exacerbate neuroinflammation and neuronal death [85]. A polymorphism in TRPM5 (rs886277) has been linked to HCV-related liver fibrosis and cirrhosis [52]. Additionally, TRMP8 has been identified as a potential target for controlling virus entry and replication [73]. Despite these findings, no direct evidence currently links TRPM channels to Flaviviridae entry or replication, representing a significant knowledge gap. TRPML The TRPML channels belong to the mucolipin subgroup of the TRP family, which consist of three members, namely TRPML1, TRPML2, and TRPML3. Among them, TRPML2 and TRPML3 have been confirmed to regulate diverse viral infections [86]. For instance, ectopically expressed TRPML2 promotes influenza A virus, DENV, YFV, and ZIKV entry and replication [87]. Similarly, TRPML3 overexpression facilitates influenza A virus infection [87]. Conversely, TRPML2 activator (ML2-SA1) treatment impairs ZIKV replication and hepatitis E virus infection [56]. Moreover, overexpression of TRPML2 activates innate immune responses, as evidenced by promoting macrophage and neutrophil migration and CCL2 secretion [88,89]. In summary, these results indicate that TRPML channels may be a promising target for combating Flaviviridae infection. Therapeutic potential of TRP channel agonists and antagonists in Flaviviridae infection Given the critical role of TRP channels in mediating Flaviviridae virus-induced abnormal intracellular Ca2+ influx and viral life-cycle, targeting TRP channels with agonists or antagonists has emerged as a promising antiviral strategy. For example, the Ca2+ channel blocker lacidipine exhibits an antiviral effect against ZIKV replication by disturbing the subcellular distribution of free cholesterol and neutral lipids in both Vero cells and neural progenitor cells [90]. Similarly, bepridil, also a Ca2+ channel blocker, has broad-spectrum anti-filovirus activity [91]. Moreover, TRP channel antagonists have been shown to have high efficacy in inhibiting viral replication by restoring host Ca2+ homeostasis or blocking virus-dependent TRP activation. For instance, the nonselective TRPC antagonist SKF96365 suppresses DENV replication in human hepatic cells by inactivation of the store-operated Ca2+ entry pathway [92]. Treatment with the selective TRPV4 inhibitor GSK2193874 not only reduces viral infectivity but also blocks Ca2+influx [68]. Doñate-Macian et al. [50] reported that the TRPV4 antagonist (compound NSC151066) reduces ZIKV replication with an IC50 of 145 nM, which exhibits a potency similar to that of HC067047. Another study showed that a TRPV4 inhibitor (HC067047) suppresses the infectivity of DENV, HCV, and ZIKV in Huh7 cells by enhancing Ca2+ influx [20]. Inversely, treatment with a specific TRPML agonist (ML-SA1) inhibits DENV and ZIKV infection by enhancing lysosome acidification and protease activity, leading to viral degradation [21]. Similarly, a TRPA1 activator cinnamodial is toxic and repellent to the yellow fever mosquito Aedes aegypti [51]. Recently, natural compounds such as bis-benzylisoquinoline alkaloids have been shown to inhibit flavivirus entry and replication by blocking TRPML channels, thereby disrupting endolysosomal trafficking and autophagy [55]. Huang et al. [54] further reported that berbamine inhibits JEV infection through suppression of TRPML-mediated endolysosomal trafficking of the low-density lipoprotein receptor. However, there are currently no TRP-targeting drugs approved for the clinical treatment of viral infection, especially those caused by Flaviviridae. Translating TRP channel antagonists or agonists into clinical use remains particularly challenging. One major concern is the widespread tissue distribution of TRP channels, which increases the risk of off-target effects. For instance, TRPV1 agonists might cause pain or hyperthermia. Moreover, since different viruses depend on specific TRP channels (e.g. HCV utilizes TRPC, whereas CSFV involves TRPML2), developing subgroup-selective modulators is essential, rather than broadly inhibiting TRP channels. Future efforts should prioritize improving the selectivity of TRP channel modulators and assessing their synergistic potential with established antiviral agents, such as direct-acting antivirals against Flaviviridae, to achieve better treatment outcomes. In summary, preclinical evidence strongly suggests that both TRP channel agonists and antagonists represent promising candidates for antiviral therapy against Flaviviridae infection. By targeting host cell Ca2+ signaling instead of viral proteins, these compounds may also decrease the likelihood of viral resistance development, positioning them as a valuable complement to existing antiviral strategies. Conclusions and future perspectives TRP channels, especially TRPC, TRPV, TRPA, and TRPM subtypes, offer distinct advantages in modulating immune responses and mitigating virus-induced pathological damage. Meanwhile, TRPML channels act as a double-edged sword, both facilitating viral replication and exhibiting antiviral effects. Based on comprehensive research, TRPC, TRPV, TRPA, TRPM, and TRPML channels are all considered promising therapeutic targets for preventing or treating Flaviviridae infection. Although the role of TRP channels in viral infection, including those caused by Flaviviridae, has been confirmed by relevant studies, several key aspects require in-depth exploration. Firstly, mechanistic understanding, including the molecular mechanism of TRP channel activation remains unclear. The regulatory effects of different localizations of TRP channels on the entry, replication, and release of Flaviviridae viruses also need further clarification. Secondly, clinical translation issues need to be further investigated. The widespread expression of TRP channels and their multiple biological functions pose challenges for drug development, and target-related side effects often limit clinical applications. Furthermore, most studies on TRP channels in Flaviviridae infection rely on in vitro models or rodent models. Therefore, future research should focus on three directions: (1) employing structural biology and proteomics to map virus-TRP channels interaction interfaces; (2) developing humanized models (such as organoids) to validate TRP-targeted therapies; and (3) exploring combination treatment strategies (e.g. TRP channel modulators with direct-acting antivirals) to enhance efficacy and reduce resistance. Addressing these research gaps will not only deepen our understanding of Flaviviridae pathogenesis but also accelerate the development of TRP channel-based therapy strategies to combat these globally impactful pathogens. In summary, this review synthesizes the current understanding of TRP channels in Flaviviridae infection, highlighting their multifaceted roles as key mediators of viral hijacking of host Ca2 + homeostasis. Preclinical studies have confirmed that treatment of TRP channel agonists and antagonists can restore host Ca2+ balance and inhibit viral entry and replication, underscoring their potential as antiviral agents.